| OLUX® is a unique formulation of the super-potent topical corticosteroid clobetasol propionate delivered in the VERSAFOAM-HF™ vehicle.
OLUX is a super-potent topical corticosteroid indicated for short-term topical treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp, and for short-term topical treatment of mild to moderate plaque-type psoriasis of non-scalp regions excluding the face and intertriginous areas.
Treatment with OLUX beyond two consecutive weeks is not recommended and the total dosage should not exceed 50 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
OLUX is not recommended for use in children under 12 years of age.
The most common adverse events that occurred in patients treated with OLUX included application site burning, application site dryness, and other application site reactions.
For more information, visit www.olux.com
Link to Package Insert
|
